SINGAPORE (July 13): The hike in average selling prices (ASPs) of Malaysian-based glove makers makes UG Healthcare a counter to watch, notes CGS-CIMB analyst Ong Khang Chuen.

“UG Healthcare remains our preferred pick among the Singapore-listed rubber glove sector, due to its undemanding valuation (a c.60% discount to the Malaysia-listed glove sector average CY21F P/E of 29.3x),” he says in a July 8 note.

Specifically, he believes the counter is able to a garner stronger average selling price (ASP) upside potential than its peers.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook